49 related articles for article (PubMed ID: 24079327)
1. A quantitative
Pedersbæk D; Jønsson K; Madsen DV; Weller S; Bohn AB; Andresen TL; Simonsen JB
RSC Adv; 2020 Jan; 10(7):3884-3894. PubMed ID: 35492676
[TBL] [Abstract][Full Text] [Related]
2. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?
Loh JS; Tan LKS; Lee WL; Ming LC; How CW; Foo JB; Kifli N; Goh BH; Ong YS
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771511
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted HDL as a therapeutic delivery device.
Fox CA; Moschetti A; Ryan RO
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Nov; 1866(11):159025. PubMed ID: 34375767
[TBL] [Abstract][Full Text] [Related]
4. Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.
Chuang ST; Cruz S; Narayanaswami V
Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32397159
[TBL] [Abstract][Full Text] [Related]
5. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells.
Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X
Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173
[TBL] [Abstract][Full Text] [Related]
6. Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma.
Scheetz LM; Yu M; Li D; Castro MG; Moon JJ; Schwendeman A
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150841
[TBL] [Abstract][Full Text] [Related]
7. Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
Wang T; Subramanian C; Yu M; White PT; Kuai R; Sanchez J; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
Surgery; 2019 Dec; 166(6):1168-1175. PubMed ID: 31371177
[TBL] [Abstract][Full Text] [Related]
8. Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.
Tsujita M; Wolska A; Gutmann DAP; Remaley AT
Curr Atheroscler Rep; 2018 Nov; 20(12):59. PubMed ID: 30397748
[TBL] [Abstract][Full Text] [Related]
9. Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.
Ma X; Song Q; Gao X
Acta Pharm Sin B; 2018 Jan; 8(1):51-63. PubMed ID: 29872622
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG-PCCL-modified magnetic iron oxide nanoparticles.
Li X; Yang Y; Jia Y; Pu X; Yang T; Wang Y; Ma X; Chen Q; Sun M; Wei D; Kuang Y; Li Y; Liu Y
Drug Deliv; 2017 Nov; 24(1):1284-1294. PubMed ID: 28891337
[TBL] [Abstract][Full Text] [Related]
11. HDL and microRNA therapeutics in cardiovascular disease.
Michell DL; Vickers KC
Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
[TBL] [Abstract][Full Text] [Related]
12. Lipoproteins and lipoprotein mimetics for imaging and drug delivery.
Thaxton CS; Rink JS; Naha PC; Cormode DP
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):116-131. PubMed ID: 27133387
[TBL] [Abstract][Full Text] [Related]
13. HDL as a drug and nucleic acid delivery vehicle.
Lacko AG; Sabnis NA; Nagarajan B; McConathy WJ
Front Pharmacol; 2015; 6():247. PubMed ID: 26578957
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
He H; Zhang M; Liu L; Zhang S; Liu J; Zhang W
Pharm Res; 2015 Oct; 32(10):3415-31. PubMed ID: 26040661
[TBL] [Abstract][Full Text] [Related]
15. Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.
McMahon KM; Foit L; Angeloni NL; Giles FJ; Gordon LI; Thaxton CS
Cancer Treat Res; 2015; 166():129-50. PubMed ID: 25895867
[TBL] [Abstract][Full Text] [Related]
16. Synthetic high-density lipoprotein-like nanoparticles for cancer therapy.
Foit L; Giles FJ; Gordon LI; Thaxton CS
Expert Rev Anticancer Ther; 2015 Jan; 15(1):27-34. PubMed ID: 25487833
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
